Attention Deficit Hyperactivity Disorder
📧 Sign up to get email alerts when something new happens for Attention Deficit Hyperactivity Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: A Comparative Effectiveness Study Evaluating OROS Methylphenidate HCl, Ritalin (Methylphenidate HCl), and Placebo for the Treatment of Attention Deficit Hyperactivity Disorder in Children [Phase 3]
A Phase 3 comparative effectiveness trial evaluated OROS methylphenidate HCl, Ritalin (methylphenidate HCl), and placebo for treating ADHD i…
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: A Multicenter Study Comparing the Efficacy and Safety of OROS Methylphenidate HCl, Ritalin (Methylphenidate HCl) and Placebo in Children With Attention Deficit Hyperactivity Disorder [Phase 3]
A multicenter Phase 3 trial evaluated the efficacy and safety of OROS methylphenidate HCl, Ritalin, and placebo in children with Attention D…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Study of the Efficacy and Safety of Risperidone in the Prevention of Relapse in Children and Adolescents With Conduct and Other Disruptive Behavior Disorders [Phase 3]
Phase 3 study evaluating the efficacy and safety of risperidone for preventing relapse in children and adolescents with conduct and other di…
-
CLINICAL_TRIALS trial_result · 2011-05-26Clinical Trial Update: Home Based Treatment for Drug Use in Early Adolescents [Phase 2]
Phase 2 clinical trial update on a home-based treatment for drug use in early adolescents, investigating conditions including Attention-Defi…
-
CLINICAL_TRIALS trial_result · 2011-05-25Clinical Trial Update: NRP104, Adderall XR or Placebo in Children Aged 6-12 Years With ADHD [Phase 2]
Phase 2 trial comparing NRP104, Adderall XR, and placebo in children aged 6-12 with ADHD has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-05-24Clinical Trial Update: A Safety and Effectiveness Study of Methylphenidate HCl Extended-release Tablets in Adults With Attention Deficit Hyperactivity Disorder [Phase 3]
A Phase 3 safety and effectiveness study of methylphenidate HCl extended-release tablets in adults with attention-deficit/hyperactivity diso…
-
CLINICAL_TRIALS trial_result · 2011-05-24Clinical Trial Update: Community-based Study Comparing Extended-release Methylphenidate and Atomoxetine in Children With Attention-deficit Hyperactivity Disorder [Phase 4]
A Phase 4 community-based trial comparing extended-release methylphenidate and atomoxetine in children with ADHD has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-24Clinical Trial Update: A Long-Term Safety Study to Evaluate Methylphenidate HCL Tablets at Multiple Dose Levels in Adults With Attention Deficit Hyperactivity Disorder [Phase 3]
This document reports the completion of a Phase 3 long-term safety study of methylphenidate HCl tablets in adults with Attention Deficit Hyp…
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: A Study of the Effectiveness and Safety of Prolonged-release Methylphenidate Hydrochloride in Adult Patients With Attention Deficit/Hyperactivity Disorder. [Phase 3]
Phase 3 study evaluating the effectiveness and safety of prolonged-release methylphenidate hydrochloride in adults with Attention-Deficit/Hy…
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: Effects of Methylphenidate on Cellular Abnormalities in Children With Attention Deficit Hyperactivity Disorder (ADHD) [Phase 2]
Phase 2 clinical trial evaluating methylphenidate's effects on cellular abnormalities in children with ADHD; results posted.
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: An Effectiveness and Safety Study of CONCERTA* vs. Immediate Release Methylphenidate (IR MPH) in Attention Deficit Hyperactivity Disorder Children [Phase 3]
A Phase 3 effectiveness and safety trial comparing CONCERTA with immediate-release methylphenidate in children with ADHD has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-06Clinical Trial Update: Safety and Efficacy of Methylphenidate in Children With Attention-deficit Hyperactivity Disorder (ADHD) [Phase 3]
Phase 3 clinical trial evaluating the safety and efficacy of methylphenidate in children with Attention Deficit Hyperactivity Disorder has c…
-
CLINICAL_TRIALS trial_result · 2011-05-05Clinical Trial Update: Proton Magnetic Spectroscopy in Children and Adolescents With ADHD Before and After Treatment With OROS Methylphenidate [Phase 4]
Phase 4 study update examining brain chemistry via Proton Magnetic Spectroscopy in children and adolescents with attention-deficit/hyperacti…
-
CLINICAL_TRIALS trial_result · 2011-04-20Clinical Trial Update: Associated Genes With Atomoxetine Response in Attention Deficit Hyperactivity Disorder (ADHD) [Phase 4]
Phase 4 clinical trial update examining genetic factors that influence atomoxetine response in Attention Deficit Hyperactivity Disorder.
-
CLINICAL_TRIALS trial_result · 2011-04-06Clinical Trial Update: Sleep and Nocturnal Melatonin in Adults With Attention Deficit Hyperactivity Disorder (ADHD) [NA]
A completed clinical trial evaluating sleep and nocturnal melatonin in adults with attention deficit hyperactivity disorder.
-
CLINICAL_TRIALS trial_result · 2011-03-28Clinical Trial Update: Vyvanse Adolescent Open-Label Safety and Efficacy Extension Study [Phase 3]
An open-label extension study for Vyvanse in adolescents evaluated safety and efficacy in a Phase 3 trial.
-
CLINICAL_TRIALS trial_result · 2011-03-16Clinical Trial Update: Efficacy and Safety of Dex-Methylphenidate Extended Release 30 mg Versus 20 mg in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting. [Phase 4]
A Phase 4 trial comparing 30 mg vs 20 mg of dexmethylphenidate extended-release in children aged 6-12 with ADHD, evaluating efficacy and saf…
-
CLINICAL_TRIALS trial_result · 2011-03-08Clinical Trial Update: Attention-Deficit/Hyperactivity Disorder (ADHD) Brain Activity Changes to Psychostimulants
A completed ADHD clinical trial reports brain activity changes associated with psychostimulant treatment.
-
CLINICAL_TRIALS trial_result · 2011-02-25Clinical Trial Update: Efficacy Of Bupropion For Attention Deficit Hyperactivity Disorder (ADHD) In Adults [NA]
Completed clinical trial evaluating the efficacy of bupropion for attention-deficit/hyperactivity disorder in adults, with participants who …
-
CLINICAL_TRIALS trial_result · 2011-02-25Clinical Trial Update: Lisdexamfetamine Dimesylate (LDX) Pilot Cognition Study to Evaluate the Utility of a Standardized Battery of Tests in Adults With Attention-Deficit Hyperactivity Disorder (ADHD) [Phase 1]
Phase 1 pilot cognition study assessing a standardized test battery for adults with ADHD using lisdexamfetamine dimesylate (LDX).
-
CLINICAL_TRIALS trial_result · 2011-02-18Clinical Trial Update: Effects of Ritalin on Postural Stability of Hyper Active Children [NA]
This completed clinical trial examined the effects of methylphenidate (Ritalin) on postural stability in children with attention-deficit/hyp…
-
CLINICAL_TRIALS trial_result · 2011-01-25Clinical Trial Update: Study of Medication Patch to Treat Children Ages 6-12 With ADHD [Phase 4]
Phase 4 study evaluating a medication patch for children aged 6-12 with Attention-Deficit/Hyperactivity Disorder; results were posted in Jan…
-
CLINICAL_TRIALS trial_result · 2011-01-20Clinical Trial Update: Lab School Day Study for CONCERTA of Older Children With ADHD [Phase 4]
Phase 4 trial results for Concerta (methylphenidate extended-release) in older children with Attention-Deficit/Hyperactivity Disorder have b…
-
CLINICAL_TRIALS trial_result · 2011-01-20Clinical Trial Update: Driving in Adults With Attention-deficit/Hyperactivity Disorder (ADHD) Before and During Treatment With Atomoxetine [Phase 4]
A Phase 4 clinical trial evaluating driving performance in adults with ADHD before and during treatment with atomoxetine (Strattera) has com…
-
CLINICAL_TRIALS trial_result · 2011-01-17Clinical Trial Update: Long-Term, Open Label Atomoxetine Study [Phase 3]
Long-term, open-label Phase 3 study of atomoxetine in attention-deficit/hyperactivity disorder completed with results posted.